Format

Send to

Choose Destination
Surg Pathol Clin. 2016 Jun;9(2):215-26. doi: 10.1016/j.path.2016.01.005. Epub 2016 Apr 12.

Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary): A Review with Recent Developments on Pathogenesis.

Author information

1
Department of Human Genetics, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec H3T1E2, Canada.
2
Department of Pediatric Oncology, McGill University, 3755 Cote Ste Catherine, Montreal, Quebec H3T1E2, Canada.
3
Department of Pathology, Royal Group of Hospitals Trust, Belfast Health and Social Care Trust, Grosvenor Road, Belfast, Northern Ireland BT12 6BA, UK. Electronic address: glenn.mccluggage@belfasttrust.hscni.net.

Abstract

Small-cell carcinoma of the ovary of hypercalcemic type (SCCOHT) is a highly malignant and aggressive tumor and is the most common undifferentiated ovarian malignancy to occur in women younger than 40. SCCOHT is characterized by deleterious germline or somatic mutations in SMARCA4. Given the striking morphologic and molecular similarities between SCCOHT and atypical teratoid/malignant rhabdoid tumor, we propose this should be reflected in a nomenclature change and that SCCOHT be renamed malignant rhabdoid tumor of the ovary. SMARCA4 (BRG1) immunohistochemistry is useful in diagnosis because there is loss of nuclear immunoreactivity in SCCOHT but retention of staining in mimics.

KEYWORDS:

Immunohistochemistry; Molecular genetics; Mutation; Ovary; SMARCA4; Small cell carcinoma of hypercalcemic type

PMID:
27241105
DOI:
10.1016/j.path.2016.01.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center